N

Natera
D

NTRA

171.900
USD
4.64
(2.77%)
مغلق
حجم التداول
47,581
الربح لكل سهم
-1
العائد الربحي
-
P/E
-98
حجم السوق
22,694,378,270
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -3.460
    (-2.00%)
    169.130 USD
    D
    DGX
    -1.120
    (-0.73%)
    151.530 USD
    E
    EXAS
    0.520
    (0.96%)
    54.780 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    TMO
    TMO
    1.41
    (0.25%)
    574.31 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Natera

القطاع: Healthcare
الصناعة: Diagnostics & Research
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.